Advertisement

Topics

Ocrevus becomes first NICE-approved therapy on the #NHS for primary progressive multiple sclerosis http://bit.ly/2Hdr2iS  #MultipleSclerosis #pharmapic.twitter.com/EWy26i2Xz1

14:15 EDT 9 May 2019 | Pharmafile

Ocrevus becomes first NICE-approved therapy on the for primary progressive multiple sclerosis http://bit.ly/2Hdr2iS 

Original Article: Ocrevus becomes first NICE-approved therapy on the #NHS for primary progressive multiple sclerosis http://bit.ly/2Hdr2iS  #MultipleSclerosis #pharmapic.twitter.com/EWy26i2Xz1

NEXT ARTICLE

More From BioPortfolio on "Ocrevus becomes first NICE-approved therapy on the #NHS for primary progressive multiple sclerosis http://bit.ly/2Hdr2iS  #MultipleSclerosis #pharmapic.twitter.com/EWy26i2Xz1"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Multiple Sclerosis MS
Multiple sclerosis (MS) is the most common disabling neurological condition affecting 100,000 young adults in the UK. The condition results from autoimmune damage to myelin, causing interference in nerve signaling. Symptoms experienced depend on the pa...